Literature DB >> 22436701

A role for aberrant protein palmitoylation in FFA-induced ER stress and β-cell death.

Aaron C Baldwin1, Christopher D Green, L Karl Olson, Michael A Moxley, John A Corbett.   

Abstract

Exposure of insulin-producing cells to elevated levels of the free fatty acid (FFA) palmitate results in the loss of β-cell function and induction of apoptosis. The induction of endoplasmic reticulum (ER) stress is one mechanism proposed to be responsible for the loss of β-cell viability in response to palmitate treatment; however, the pathways responsible for the induction of ER stress by palmitate have yet to be determined. Protein palmitoylation is a major posttranslational modification that regulates protein localization, stability, and activity. Defects in, or dysregulation of, protein palmitoylation could be one mechanism by which palmitate may induce ER stress in β-cells. The purpose of this study was to evaluate the hypothesis that palmitate-induced ER stress and β-cell toxicity are mediated by excess or aberrant protein palmitoylation. In a concentration-dependent fashion, palmitate treatment of RINm5F cells results in a loss of viability. Similar to palmitate, stearate also induces a concentration-related loss of RINm5F cell viability, while the monounsaturated fatty acids, such as palmoleate and oleate, are not toxic to RINm5F cells. 2-Bromopalmitate (2BrP), a classical inhibitor of protein palmitoylation that has been extensively used as an inhibitor of G protein-coupled receptor signaling, attenuates palmitate-induced RINm5F cell death in a concentration-dependent manner. The protective effects of 2BrP are associated with the inhibition of [(3)H]palmitate incorporation into RINm5F cell protein. Furthermore, 2BrP does not inhibit, but appears to enhance, the oxidation of palmitate. The induction of ER stress in response to palmitate treatment and the activation of caspase activity are attenuated by 2BrP. Consistent with protective effects on insulinoma cells, 2BrP also attenuates the inhibitory actions of prolonged palmitate treatment on insulin secretion by isolated rat islets. These studies support a role for aberrant protein palmitoylation as a mechanism by which palmitate enhances ER stress activation and causes the loss of insulinoma cell viability.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22436701      PMCID: PMC3378068          DOI: 10.1152/ajpendo.00519.2011

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  83 in total

1.  Biochemistry and molecular cell biology of diabetic complications.

Authors:  M Brownlee
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

Review 2.  The on-off story of protein palmitoylation.

Authors:  Marie-José Bijlmakers; Mark Marsh
Journal:  Trends Cell Biol       Date:  2003-01       Impact factor: 20.808

3.  Palmitate-induced apoptosis can occur through a ceramide-independent pathway.

Authors:  L L Listenberger; D S Ory; J E Schaffer
Journal:  J Biol Chem       Date:  2001-02-13       Impact factor: 5.157

4.  Lipotoxicity of the pancreatic beta-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids.

Authors:  I Briaud; J S Harmon; C L Kelpe; V B Segu; V Poitout
Journal:  Diabetes       Date:  2001-02       Impact factor: 9.461

5.  Glucolipotoxicity alters lipid partitioning and causes mitochondrial dysfunction, cholesterol, and ceramide deposition and reactive oxygen species production in INS832/13 ss-cells.

Authors:  Wissal El-Assaad; Erik Joly; Annie Barbeau; Robert Sladek; Jean Buteau; Isabel Maestre; Emilie Pepin; Shangang Zhao; José Iglesias; Enrique Roche; Marc Prentki
Journal:  Endocrinology       Date:  2010-05-05       Impact factor: 4.736

6.  Structure-activity studies of cerulenin analogues as protein palmitoylation inhibitors.

Authors:  D S Lawrence; J T Zilfou; C D Smith
Journal:  J Med Chem       Date:  1999-12-02       Impact factor: 7.446

7.  Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress.

Authors:  Salvatore Piro; Marcello Anello; Cinzia Di Pietro; Maria Natalia Lizzio; Giovanni Patanè; Agata Maria Rabuazzo; Riccardo Vigneri; Michele Purrello; Francesco Purrello
Journal:  Metabolism       Date:  2002-10       Impact factor: 8.694

8.  Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes.

Authors:  Seiichi Oyadomari; Akio Koizumi; Kiyoshi Takeda; Tomomi Gotoh; Shizuo Akira; Eiichi Araki; Masataka Mori
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

9.  Structural determinants influencing the reaction of cysteine-containing peptides with palmitoyl-coenzyme A and other thioesters.

Authors:  O A Bizzozero; H A Bixler; A Pastuszyn
Journal:  Biochim Biophys Acta       Date:  2001-02-09

10.  Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated.

Authors:  Roberto Lupi; Francesco Dotta; Lorella Marselli; Silvia Del Guerra; Matilde Masini; Carmela Santangelo; Giovanni Patané; Ugo Boggi; Salvatore Piro; Marcello Anello; Ettore Bergamini; Franco Mosca; Umberto Di Mario; Stefano Del Prato; Piero Marchetti
Journal:  Diabetes       Date:  2002-05       Impact factor: 9.461

View more
  41 in total

1.  Icariin prevents cytokine-induced β-cell death by inhibiting NF-κB signaling.

Authors:  Shao Zhong; Jing Ge; Jiang-Yi Yu
Journal:  Exp Ther Med       Date:  2018-07-20       Impact factor: 2.447

2.  Temporal Proteomic Analysis of Pancreatic β-Cells in Response to Lipotoxicity and Glucolipotoxicity.

Authors:  Zonghong Li; Hongyang Liu; Zhangjing Niu; Wen Zhong; Miaomiao Xue; Jifeng Wang; Fuquan Yang; Yue Zhou; Yifa Zhou; Tao Xu; Junjie Hou
Journal:  Mol Cell Proteomics       Date:  2018-08-06       Impact factor: 5.911

3.  Glut4 palmitoylation at Cys223 plays a critical role in Glut4 membrane trafficking.

Authors:  Wenying Ren; Yingmin Sun; Keyong Du
Journal:  Biochem Biophys Res Commun       Date:  2015-03-27       Impact factor: 3.575

Review 4.  The impact of the endoplasmic reticulum protein-folding environment on cancer development.

Authors:  Miao Wang; Randal J Kaufman
Journal:  Nat Rev Cancer       Date:  2014-09       Impact factor: 60.716

Review 5.  On the existence of endocytosis driven by membrane phase separations.

Authors:  Donald W Hilgemann; Mei-Jung Lin; Michael Fine; Christine Deisl
Journal:  Biochim Biophys Acta Biomembr       Date:  2019-06-13       Impact factor: 3.747

6.  Activity-Based Sensing of S-Depalmitoylases: Chemical Technologies and Biological Discovery.

Authors:  Saara-Anne Azizi; Rahul S Kathayat; Bryan C Dickinson
Journal:  Acc Chem Res       Date:  2019-10-02       Impact factor: 22.384

7.  Upregulation of phagocyte-like NADPH oxidase by cytokines in pancreatic beta-cells: attenuation of oxidative and nitrosative stress by 2-bromopalmitate.

Authors:  Abiy M Mohammed; Khadija Syeda; Timothy Hadden; Anjaneyulu Kowluru
Journal:  Biochem Pharmacol       Date:  2012-10-23       Impact factor: 5.858

8.  Cation-Independent Mannose 6-Phosphate Receptor Deficiency Enhances β-Cell Susceptibility to Palmitate.

Authors:  Aaron C Baldwin; Aaron Naatz; Richard N Bohnsack; Jacob T Bartosiak; Bryndon J Oleson; Polly A Hansen; Nancy M Dahms; John A Corbett
Journal:  Mol Cell Biol       Date:  2018-03-29       Impact factor: 4.272

9.  Fatty acid-mediated endoplasmic reticulum stress in vivo: differential response to the infusion of Soybean and Lard Oil in rats.

Authors:  Angela M Nivala; Lauren Reese; Melinda Frye; Christopher L Gentile; Michael J Pagliassotti
Journal:  Metabolism       Date:  2013-01-10       Impact factor: 8.694

Review 10.  Endoplasmic reticulum stress in obesity and obesity-related disorders: An expanded view.

Authors:  Michael J Pagliassotti; Paul Y Kim; Andrea L Estrada; Claire M Stewart; Christopher L Gentile
Journal:  Metabolism       Date:  2016-05-12       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.